Skip to main content
. Author manuscript; available in PMC: 2026 Feb 1.
Published in final edited form as: J Am Soc Echocardiogr. 2024 Oct 1;38(2):115–126. doi: 10.1016/j.echo.2024.09.010

Table 2. Hemodynamic and Echocardiographic Characteristics by WSPH Classification.

Abbreviations: CI=cardiac index, CO=cardiac output, Ea=effective arterial elastance, Ees= end-systolic elastance, RA=right atrium, RV=right ventricle, PA=pulmonary artery, PAH=pulmonary arterial hypertension, PCWP=pulmonary capillary wedge pressure, PH=pulmonary hypertension, SSc=systemic sclerosis, WSPH=World Symposium of Pulmonary Hypertension.

Entire Study Cohort (n=42) SSc no PH (n=9) SSc PH (n=20+5 +8) SSc-PAH (n=20) SSc-HFpEF-PH (n=5) SSc-ILD-PH (n=8) p-value* p-value#
Hemodynamic Parameters
Heart Rate (bpm) 73 ± 10 75 ± 10 73 ± 10 74 ± 10 69 ± 7 73 ± 13 0.63 0.81
Systolic Blood Pressure (mmHg) 131 ± 20 144 ± 11 127 ± 20 127 ± 19 138 ± 24 123 ± 19 0.02 0.07
Diastolic Blood Pressure (mmHg) 71 ± 10 69 ± 8 71 ± 10 71 ± 12 73 ± 12 71 ± 7 0.48 0.90
RA pressure (mmHg) 6.3 ± 4.1 3.4 ± 0.9 6.9 ± 4.3 7.5 ± 4.7 8.6 ± 1.9 4.6 ± 3.5 0.02 0.02
RV systolic pressure (mmHg) 48.3 ± 21.6 30.7 ± 5.3 53.8 ± 21.8 61.0 ± 24.6 40.2 ± 7.9 40.6 ± 8.0 0.003 0.001
RV diastolic pressure (mmHg) 7.3 ± 4.8 3.7 ± 1.2 8.6 ± 5.4 9.3 ± 5.4 9.4 ± 3.3 5.3 ± 3.4 0.01 0.009
PA systolic pressure (mmHg) 48.9 ± 21.3 30.6 ± 6.3 53.9 ± 21.2 61.7 ± 23.8 41.2 ± 7.4 42.3 ± 7.4 0.003 0.0005
PA diastolic pressure (mmHg) 18.2 ± 8.0 10.2 ± 1.9 20.2 ± 7.9 22.6 ± 8.6 18.6 ± 4.5 16 ± 4.1 0.0006 0.0004
Mean PA pressure (mmHg) 29.5 ± 12.8 17.3 ± 3.1 32.8 ± 12.4 37.3 ± 13.6 27 ± 6.5 25.3 ± 5.8 0.0007 0.0002
PCWP (mmHg) 10.3 ± 4.1 9.1 ± 2.4 10.7 ± 4.4 10.2 ± 3.9 16.2 ± 4.3 8.6 ± 3.0 0.30 0.003
PVR (WU) 4.7 ± 4.2 1.9 ± 0.9 5.6 ± 4.3 7.0 ± 4.9 2.5 ± 1.8 3.9 ± 1.4 0.02 0.004
CO (L/min) 4.7 ± 1.3 4.6 ± 0.8 4.7 ± 1.3 4.6 ± 1.3 5.4 ± 2.4 4.5 ± 0.8 0.88 0.58
CI (L/min/m2) 2.6 ± 0.6 2.6 ± 0.3 2.6 ± 0.7 2.5 ± 0.6 2.7 ± 1.2 2.5 ± 0.5 0.79 0.96
PA saturation (%) 68.3 ± 5.2 70.6 ± 3.1 67.7 ± 5.5 66.6 ± 5.9 68.7 ± 6.1 70.1 ± 3.7 0.19 0.24
Ea (mmHg/mL) 0.72 ± 0.47 0.42 ± 0.14 0.82 ± 0.56 0.95 ± 0.56 0.43 ± 0.17 0.66 ± 0.24 0.03 0.02
Ees (mmHg/mL) 0.63 ± 0.32 0.81 ± 0.42 0.58 ± .28 0.57 ± 0.17 0.52 ± 0.12 0.66 ± 0.51 0.07 0.02
Ees/Ea 1.13 ± 0.83 2.05 ± 1.06 0.91 ± 0.56 0.78 ± 0.48 1.29 ± 0.42 1.03 ± 0.74 0.0001 0.0005
Echocardiographic Parameters
LV Ejection Fraction, % 60 ± 8 61 ± 8 60 ± 8 61 ± 7 56 ± 11 59 ± 8 0.78 0.72
Mitral E/A ratio 1.1 ± 0.4 0.9 ± 0.2 1.2 ± 0.5 1.1 ± 0.3 1.7 ± 0.9 1.1 ± 0.4 0.12 0.24
E/e’ (n=27) 11.8 ± 5.3 10.6 ± 6.6 12.1 ± 5.6 12.4 ± 5.8 12.2 ± 3.6 11.1 ± 6.8 0.60 0.66
RA Area, cm2 15.1 ± 4.4 13.1 ± 3.4 15.6 ± 4.6 15.3 ± 4.3 18.7 ± 6.7 14.1 ± 2.8 0.14 0.26
RV basal diameter, cm 3.8 ± 0.7 3.7 ± 0.8 3.8 ± 0.6 4.0 ± 0.7 3.7 ± 0.3 3.5 ± 0.6 0.49 0.33
RVEDd, cm 3.1 ± 0.5 3.0 ± 0.6 3.2 ± 0.4 3.1 ± 0.4 3.1 ± 0.4 3.2 ± 0.5 0.72 0.95
RVEDA, cm2 20.2 ± 6.6 17.3 ± 6.7 21.0 ± 6.4 21.2 ± 6.6 22.0 ± 6.5 19.4 ± 6.6 0.10 0.33
RVESA, cm2 12.4 ± 5.8 10.2 ± 6.4 12.9 ± 5.6 13.8 ± 6.0 10.9 ± 2.5 12.0 ± 6.2 0.10 0.30
TAPSE, mm, n=32 17.9 ± 5.0 18.8 ± 6.3 17.6 ± 4.6 17.1 ± 3.9 21.0 ± 8.0 16.8 ± 3.3 0.18 0.29
PASP, mmHg, n=29 46.0 ± 22.1 28.3 ± 5.6 50.6 ± 22.4 60.6 ± 25.7 35 ± 4.2 39.3 ± 3.7 0.0001 0.0009
TDI S’ Velocity, cm/s, n=21 11.5 ± 4.0 10.9 ± 3.0 11.7 ± 4.2 9.7 ± 1.7 16.2 ± 6.0 11.6 ± 3.3 .65 .27
FAC, % 40.7 ± 11.1 44.3 ± 11.7 39.7 ± 10.8 36.9 ± 10.6 49.2 ± 7.3 40.5 ± 10.5 0.25 0.07
Basal RVFWS, % −22.4 ± 7.7 −25.8 ± 6.9 −21.6 ± 6.9 −22.1 ± 5.9 −23.0 ± 11.3 −19.5 ± 6.6 0.06 0.24
Midventricular RVFWS, % −18.3 ± 6.1 −18.7 ± 3.0 −18.2 ± 6.6 −18.9 ± 7.2 −17.8 ± 4.1 −16.7 ± 6.5 0.85 0.97
Apical RVFWS, % −12.3 ± 6.6 −11.1 ± 6.0 −12.5 ± 6.8 −12.2 ± 7.6 −13.6 ± 6.7 −12.6 ± 5.4 0.67 0.94
Global RVFWS, % −17.7 ± 5.2 −18.5 ± 4.3 −17.5 ± 5.5 −17.9 ± 5.5 −18.2 ± 6.5 −16.0 ± 5.2 0.65 0.79
RA reservoir strain, % 25.9 ± 8.1 22.7 ± 5.0 26.7 ± 8.7 26.0 ± 7.8 32.2 ± 9.6 24.8 ± 10.4 0.28 0.32
RA booster strain, % −12.7 ± 5.9 −9.5 ± 4.9 −13.5 ± 5.9 −13.1 ± 5.9 −15.8 ± 6.8 −13.2 ± 5.9 0.12 0.37
RA conduit strain, % −13.8 ± 5.3 −14.1 ± 5.9 −13.6 ± 5.3 −13.6 ± 5.1 −16.2 ± 4.8 −12 ± 6.2 0.92 0.68
TAPSE/PASP, mm/mmHg, n=25 0.49 ± 0.26 0.75 ± 0.25 0.41 ± 0.20 0.30 ± 0.12 0.62 ± 0.31 0.42 ± 0.09 0.001 0.003
FAC/PASP, %/mmHg, n=29 1.09 ± 0.61 1.79 ± 0.50 0.89 ± 0.48 0.72 ± 0.47 1.41 ± 0.39 0.94 ± 0.26 0.0009 0.0002
TDI S’/PASP, cm/s/mmHg, n=17 0.31 ± 0.18 0.41 ± 0.11 0.29 ± 0.19 0.16 ± 0.09 0.48 ± 0.21 0.27 ± 0.05 0.10 0.02
Global RVFWS/PASP, %/mmHg, n=29 −0.43 ± 0.22 −0.72 ± 0.19 −0.39 ± 0.19 −0.33 ± 0.20 −0.56 ± 0.10 −0.39 ± 0.14 0.01 0.01
Basal RVFWS/PASP, %/mmHg, n=29 −0.55 ± 0.34 −0.85 ± 0.53 −0.48 ± 0.24 −0.42 ± 0.24 −0.69 ± 0.26 −0.48 ± 0.17 0.11 0.12
RA reservoir strain/PASP, %/mmHg, n=21 0.69 ± 0.35 0.67 ± 0.36 0.62 ± 0.38 0.94 ± 0.33 0.51 ± 0.23 0.51 ± 0.23 0.37 0.28
Pericardial effusion, n (%)
 None, n (%) 32 (76) 8 (89) 24 (73) 14 (70) 0 (100) 5 (63) 0.76 0.53
 Mild, n (%) 9 (21) 1 (11) 8 (24) 6 (30) 0 (0) 2 (25)
 Moderate, n (%) 1 (3) 0 (0) 1 (3) 0 (0) 0 (0) 3 (12)
*

p-value represents comparison between SSc no PH and SSc-PH

#

p-value represents SSc no PH vs. SSc-PAH vs. SSc-HFpEF-PH vs. SSc-ILD-PH

Bolded font signifies statistical significance, p-value<0.05